Advertisement

Advertisement

Announcements

Breast Cancer

Armando E. Giuliano, MD, To Be Honored With 2025 William L. McGuire Memorial Lecture Award at SABCS

The ASCO Post Staff  /  December 10, 2025

Armando E. Giuliano, MD, will receive the William L. McGuire Memorial Lecture Award during the 2025 San Antonio Breast Cancer Symposium (SABCS). Dr. Giuliano is being recognized for his pioneering work on sentinel lymph node biopsy for patients with breast cancer, which has transformed the surgica...

Armando E. Giuliano, MD, To Be Honored With 2025 William L. McGuire Memorial Lecture Award at SABCS

The ASCO Post Staff  /  November 10, 2025

Armando E. Giuliano, MD, will receive the William L. McGuire Memorial Lecture Award during the 2025 San Antonio Breast Cancer Symposium (SABCS). Dr. Giuliano is being recognized for his pioneering work on sentinel lymph node biopsy for patients with breast cancer, which has transformed the surgica...

Breast Cancer
AI in Oncology

AI Tops Density in Predicting Breast Cancer Risk

The ASCO Post Staff  /  December 10, 2025

An image-only artificial intelligence (AI) model for predicting the 5-year risk of breast cancer provided stronger and more precise risk stratification than breast density assessment, according to a news statement issued about a study presented at the annual meeting of the Radiological Society of No...

Christine M. Lovly, MD, PhD, FASCO, Named Head, Thoracic Oncology, at City of Hope

The ASCO Post Staff  /  December 10, 2025

Christine M. Lovly, MD, PhD, FASCO, an expert on lung cancer with almost 2 decades of experience in clinical care, translational research, and academic leadership, will spearhead the new national thoracic oncology program at City of Hope in Duarte, California. In her new role, effective January 1,...

Mount Sinai Tisch Cancer Center Receives Comprehensive Cancer Center Designation and Funding from National Cancer Institute

The ASCO Post Staff  /  December 10, 2025

The Mount Sinai Tisch Cancer Center (TCC) has been named a Comprehensive Cancer Center by the National Cancer Institute (NCI), the highest designation awarded to cancer centers in the United States. This recognition places Mount Sinai among the top one percent of cancer centers nationwide and affirm...

ASH Recognizes Leaders for Support of Patient Care and Research

The ASCO Post Staff  /  December 10, 2025

The American Society of Hematology (ASH) will honor U.S. Senators Susan Collins (R-ME), Patty Murray (D-WA), Shelley Moore Capito (R-WV), and Tammy Baldwin (D-WI), as well as the patient groups Sick Cells, The Sickle Cell Disease Association of America (SCDAA), and The Sickle Cell Disease Consortium...

Rainer Storb, MD, Receives Distinguished Wallace H. Coulter Award at ASH Annual Congress

The ASCO Post Staff  /  December 10, 2025

The American Society of Hematology (ASH) presented the Wallace H. Coulter Award for Lifetime Achievement in Hematology to Rainer Storb, MD, during the Society’s Annual Congress held in Orlando. Dr. Storb is Professor Emeritus, Clinical Research Division, at Fred Hutch in Seattle. First awarded in...

Genomics/Genetics
Breast Cancer
Gynecologic Cancers
Pancreatic Cancer
Prostate Cancer

Basser Center for BRCA Announces Two Award Winners

The ASCO Post Staff  /  December 10, 2025

The Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, the world’s first comprehensive center aimed at advancing research, treatment, and prevention of BRCA-related cancers, is honoring Alan D. D'Andrea, MD, of Dana-Farber Cancer Institute, with the 2025 BRCA Imp...

Ross Levine, MD, Named Chief Scientific Officer of Memorial Sloan Kettering Cancer Center

The ASCO Post Staff  /  December 10, 2025

Memorial Sloan Kettering Cancer Center (MSK) announced that Ross Levine, MD, has been named MSK’s new Chief Scientific Officer (CSO). Dr. Levine previously served as Senior Vice President of Translational Research in Memorial Hospital (MH) and holds the Edward P. Evans Endowed Chair for Myelodysplas...

American Cancer Society Launches Nationwide Program to Increase Equity in Clinical Trials

The ASCO Post Staff  /  December 10, 2025

For individuals diagnosed with cancer, participation in a clinical trial offers the opportunity to explore new treatment options; however, for many, finding and navigating the right clinical trial can be challenging due to various barriers in the process. To address these issues, the American Canc...

SOHO 2025 Keynote Speakers Highlight Progress in Hematologic Oncology

The ASCO Post Staff  /  December 10, 2025

Three Plenary Sessions were presented recently at the 2025 Annual Meeting of the Society of Hematologic Oncology (SOHO 2025), which focused specifically on new advances and practical clinical applications in the field of hematologic malignancies. The theme of SOHO 2025 was “Unleashing AI, Genomics, ...

Prostate Cancer

ASTRO Marks Former President Biden’s Prostate Cancer Treatment Milestone

The ASCO Post Staff  /  December 10, 2025

The American Society for Radiation Oncology (ASTRO) congratulates former President Joe Biden on completing his course of radiation therapy, which he marked by ringing the ceremonial bell alongside his radiation oncology care team. “President Biden’s bell-ringing milestone underscores the vital role...

ASTRO Recognizes 2025 Award Recipients for Excellence in Radiation Oncology

The ASCO Post Staff  /  November 25, 2025

During its recent Annual Meeting, the American Society for Radiation Oncology (ASTRO) honored the recipients of its 2025 Gold Medal awards and other prestigious distinctions. Here, The ASCO Post celebrates the achievements of these leading radiation oncology experts. Gold Medal The Gold Medal is A...

Memorial Sloan Kettering Names Recipients of 2025 Paul Marks Prize for Cancer Research

The ASCO Post Staff  /  November 25, 2025

Memorial Sloan Kettering Cancer Center (MSK) will award three cancer researchers with this year’s Paul Marks Prize for Cancer Research. The prize, named in honor of former MSK president Paul Marks, MD, recognizes a new generation of leaders who are making significant contributions to the understandi...

Project DISARM: New Cancer Mission Emphasizes Risk Assessment and Early Detection of Ovarian Cancer

The ASCO Post Staff  /  November 25, 2025

Often referred to as a “silent killer,” ovarian cancer is the most lethal of female cancers. Issues of late detection and poor survival rates continue to persevere, leading to increasing levels of incidence and mortality. Data from the World Ovarian Cancer Coalition have stressed that ovarian cancer...

Icahn School of Medicine Family Center for Caregiving Launches Website to Further Reach and Broaden Mission

The ASCO Post Staff  /  November 25, 2025

Allison J. Applebaum, PhD, FAPOS, recently announced the launch of the website for the Steven S. Elbaum Family Center for Caregiving at the Icahn School of Medicine at Mount Sinai in New York (www.mountsinai.org/care/palliative-care/elbaum-center-caregiving). Dr. Applebaum is Director of the Cent...

ASTRO Announces New President-Elect, Officers to Board of Directors

The ASCO Post Staff  /  November 10, 2025

The members of the American Society for Radiation Oncology (ASTRO) recently elected four new officers to ASTRO’s Board of Directors: Catheryn M. Yashar, MD, FASTRO, President-Elect; Jonathan Strauss, MD, MBA, Secretary/Treasurer-Elect; Anita Mahajan, MD, FASTRO, Health Policy Council Vice Chair; and...

Anthony Letai, MD, PhD, Takes the Helm as New NCI Director

The ASCO Post Staff  /  October 25, 2025

Anthony Letai, MD, PhD, was sworn in on September 29 as Director of the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), by Health and Human Services Secretary Robert F. Kennedy, Jr. Dr. Letai takes the helm of the world’s most prestigious cancer research agency aft...

Lung Cancer

City of Hope Awarded $23.7 Million to Map Biomarkers in NSCLC

The ASCO Post Staff  /  September 25, 2025

City of Hope® has been awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health (ARPA-H) within the U.S. Department of Health and Human Services. The grant will help City of Hope to create a biomap of tumor changes that cause immunotherapy resistance in advanced ...

OHSU Knight Cancer Institute Receives $2 Billion Commitment From Phil and Penny Knight

The ASCO Post Staff  /  September 10, 2025

Phil Knight, co-founder of Nike, and Penny Knight announced today a record-breaking $2 billion gift to the Oregon Health & Science University’s (OHSU) Knight Cancer Institute to transform the future of cancer care and set a new standard globally. It is the largest single donation ever made to a...

Jeffrey A. Drebin, MD, PhD, Named Chief Physician Executive of Memorial Sloan Kettering Cancer Center

The ASCO Post Staff  /  September 10, 2025

Memorial Sloan Kettering Cancer Center (MSK) recently announced that Jeffrey A. Drebin, MD, PhD, has been named Chief Physician Executive. A renowned surgeon-scientist, Dr. Drebin previously served as Chair of the Department of Surgery and brings decades of leadership and clinical experience special...

Radiation Oncology Leaders Name 2025 Fellows of the American Society for Radiation Oncology

The ASCO Post Staff  /  September 10, 2025

The American Society for Radiation Oncology (ASTRO) selected 43 members to receive the ASTRO Fellow (FASTRO) designation this year. This prestigious honor recognizes ASTRO members’ outstanding achievements and contributions to the Society, cancer research, education, patient care, and the specialty....

ASH Announces 2025 Hematologists to Be Honored With Top Awards and Distinguished Lectures

The ASCO Post Staff  /  August 25, 2025

The American Society of Hematology (ASH) will recognize 11 hematologists who have made significant contributions to the field with several honorific awards and prestigious lectures at the 2025 ASH Annual Meeting & Exposition in Orlando, Florida, on December 6–9. Rainer Storb, MD, of Fred Hutchi...

ASCO Names 2025 Q1, Q2 FASCO Recipients

The ASCO Post Staff  /  August 25, 2025

Launched in 2007 and formerly called the ASCO Statesman Award, the FASCO distinction honors members for their extraordinary volunteer service, engagement, and dedication to American Society of Clinical Oncology and the Association for Clinical Oncology (collectively ASCO). Listed here are the FASCO ...

Minnesota Society of Clinical Oncology Recognized for Advocacy at 2025 ASCO Annual Meeting

The ASCO Post Staff  /  June 25, 2025

The Minnesota Society of Clinical Oncology (MSCO) is the recipient of the 2024 Jeffery C. Ward Affiliate Advocacy Award. The Association for Clinical Oncology presented the award during the State Affiliates’ Reception at the 2025 ASCO Annual Meeting. Presented annually, the Jeffery C. Ward Affiliate...

Prostate Cancer

AACR Statement on Former President Joseph Biden’s Cancer Diagnosis

The ASCO Post Staff  /  June 10, 2025

The American Association for Cancer Research (AACR) has issued the following statement regarding former President Joseph R. Biden’s prostate cancer diagnosis: “The American Association for Cancer Research (AACR) offers heartfelt support and well wishes to former President Biden and his family as ...

The Ohio State Appoints Christian Rolfo, MD, PhD, MBA, to Lead Division of Medical Oncology

The ASCO Post Staff  /  June 25, 2025

Christian Rolfo, MD, PhD, MBA, has been appointed Director of the Division of Medical Oncology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James). He will assume this position on August 15. Dr. Rolfo wil...

W. Kimryn Rathmell, MD, PhD, FASCO, Selected for Women Who Conquer Cancer Mentorship Award

The ASCO Post Staff  /  June 25, 2025

W. Kimryn Rathmell, MD, PhD, FASCO, has been selected for the prestigious 2025 Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award. Launched in 2016, the Women Who Conquer Cancer award program honors extraordinary women leaders in oncology and role models who have excelled as mentors an...

ASCO Honors Karen Eubanks Jackson of Sisters Network® Inc. With 2025 Patient Advocate Award

The ASCO Post Staff  /  June 25, 2025

Karen Eubanks Jackson, founder and Chief Executive Officer of Sisters Network® Inc. (SNI), has been named the recipient of the 2025 Patient Advocate Award by ASCO, Conquer Cancer, and the ASCO Foundation. The awards ceremony was held during the 2025 ASCO Annual Meeting. (See a video with Ms. Jacks...

Issues in Oncology

ACS Study Focuses on Effects of Medicaid Expansion in Low-Income Older Adults With Cancer

The ASCO Post Staff  /  June 25, 2025

A recent study by researchers at the American Cancer Society (ACS) showed that Medicaid expansion was associated with an increase in Medicaid coverage, early-stage cancer diagnoses, and improved 2-year survival among individuals aged 65 or older who were diagnosed with cancer. They believe these fin...

Breast Cancer

Renowned Breast Cancer Physician-Scientist Hope S. Rugo, MD, FASCO, to Lead Women’s Cancers Program at City of Hope

The ASCO Post Staff  /  May 10, 2025

Hope S. Rugo, MD, FASCO, recently joined the staff of City of Hope as the new Director of the Women’s Cancers Program, Division Chief of Breast Medical Oncology, and Professor in the Department of Medical Oncology and Therapeutics Research. In her role, she will lead and enhance City of Hope’s women...

MD Anderson Names Jeffrey E. Lee, MD, Chief Medical Executive

The ASCO Post Staff  /  June 10, 2025

The University of Texas MD Anderson Cancer Center announced that Jeffrey E. Lee, MD, an internationally regarded leader in the field of oncology, has been appointed Chief Medical Executive (CME). Prior to his appointment, Dr. Lee served as CME ad interim. Assuming the role of CME is the culminatio...

W. Kimryn Rathmell, MD, PhD, FASCO, Named CEO of OSUCCC-James

The ASCO Post Staff  /  May 25, 2025

Following a comprehensive national search, W. Kimryn Rathmell, MD, PhD, FASCO, former Director of the National Cancer Institute (NCI), has accepted the role of Chief Executive Officer (CEO) of The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove...

Fellows of the AACR Academy Class of 2025

The ASCO Post Staff  /  May 25, 2025

Listed here is the newly elected 2025 class of Fellows of the American Academy for Cancer Research (AACR) Academy, which was recognized at the AACR Annual Meeting, April 25–30, 2025, in Chicago. Rafi Ahmed, PhD, Atlanta, Georgia Sir Shankar Balasubramanian, PhD, Cambridge, UK Bradley Bernstein, M...

Health-Care Policy

Association for Clinical Oncology: Proposed Changes to Federal Health Agencies Threaten Future Cancer Research Advancements

ASCO  /  May 25, 2025

The Association for Clinical Oncology is carefully reviewing the Administration’s Fiscal Year 2026 (FY 2026) budget proposal, which was released on May 2 and contains significant cuts to federal health agencies under the Department of Health and Human Services (HHS), notably a 40% cut to the overa...

Integrative Oncology

Applications Are Now Open for the 2025 Integrative Oncology Scholars Program and Integrative Oncology Fellows Program

Jo Cavallo  /  May 10, 2025

Applications are now being accepted for the 2025 Integrative Oncology Scholars Program and Integrative Oncology Fellows Program at the University of Michigan in Ann Arbor (https://sites.google.com/view/integrative-oncology-scholars-/home). Launched in 2018, the Integrative Oncology Scholars Program ...

Rakesh K. Jain, PhD, FAACR, Honored With 2025 AACR Award for Lifetime Achievement in Cancer Research

The ASCO Post Staff  /  May 10, 2025

The 2025 AACR Award for Lifetime Achievement in Cancer Research was presented to Rakesh K. Jain, PhD, FAACR, during the 2025 American Association for Cancer Research (AACR) Annual Meeting in Chicago. This award honors individuals who have made significant fundamental contributions to cancer resear...

Keith T. Flaherty, MD, FAACR, Elected as AACR President-Elect for 2025–2026

The ASCO Post Staff  /  May 10, 2025

The members of the American Association for Cancer Research (AACR) have elected Keith T. Flaherty, MD, FAACR, as the AACR President-Elect for 2025–2026. He will assume the Presidency in April 2026 at the AACR Annual Meeting in San Diego. Dr. Flaherty is Director of Clinical Cancer Research and th...

Karen E. Knudsen, MBA, PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy

The ASCO Post Staff  /  April 25, 2025

The Parker Institute for Cancer Immunotherapy (PICI) announced the appointment of Karen E. Knudsen, MBA, PhD, as its new Chief Executive Officer (CEO). A visionary leader in oncology, health-care delivery, scientific innovation, and strategic transformation, Dr. Knudsen joins PICI at a pivotal time ...

SGO’s President-Elect Brings Professional Experience and Passion to Her New Role

The ASCO Post Staff  /  April 25, 2025

Society of Gynecologic Oncology (SGO) President-Elect Karen Lu, MD, assumed her official duties on March 17, 2025. Dr. Lu, who is also Executive Vice President and Physician-in-Chief at Moffitt Cancer Center in Tampa, Florida, brings many years of professional experience and active SGO membership to...

Conexiant Signs Partnership Deal With Elsevier to Enhance Society Marketing and Member Engagement Solutions

The ASCO Post Staff  /  March 25, 2025

Conexiant has partnered with Elsevier to deliver world-class solutions and sales execution to more than 100 global societies and associations covering more than 25 core specialties in the health-care space. This collaboration marks a significant step forward in delivering innovative advertising, con...

Issues in Oncology

New Reports Assess Oncology Workforce Well-Being, Propose Solutions to Address Burnout

The ASCO Post Staff  /  March 25, 2025

Physician burnout has increased significantly in the past decade, and organizational strategies are vital to improve physician well-being, according to new research from ASCO. This compilation includes reports on the state of professional well-being among oncologists in 2023, burnout trends among on...

Breast Cancer

Results Announced From Phase II VERITAC-2 Clinical Trial in Breast Cancer

The ASCO Post Staff  /  March 25, 2025

Arvinas, Inc. and Pfizer Inc. recently announced results from the randomized phase III VERITAC-2 clinical trial (ClinicalTrials.gov identifier NCT05654623) evaluating vepdegestrant monotherapy vs fulvestrant in adults with estrogen receptor–positive, HER2-negative advanced or metastatic breast cance...

Issues in Oncology

CMS Expects Between 750,000 to 2 Million to Lose Coverage If ACA Proposal Is Implemented

The ASCO Post Staff  /  March 25, 2025

On March 10, 2025, the Centers for Medicare & Medicaid Services (CMS) released the Marketplace Integrity and Affordability Proposed Rule aimed at addressing improper enrollments in the Affordable Care Act (ACA) Health Insurance Marketplace. This is the first proposed rule released under the new ...

Douglas Hanahan, PhD, FAACR, to Be Honored at 2025 AACR Annual Meeting

The ASCO Post Staff  /  March 25, 2025

The Pezcoller Foundation–American Association for Cancer Research (AACR) International Award for Extraordinary Achievement in Cancer Research will be presented to Douglas Hanahan, PhD, FAACR, during the upcoming 2025 AACR Annual Meeting, to be held April 25–30 at the McCormick Place Convention Cente...

Monica M. Bertagnolli, MD, FACS, FASCO, Joins Friends of Cancer Research Board of Directors

The ASCO Post Staff  /  March 25, 2025

Friends of Cancer Research (Friends) is honored to announce the addition of former Director of the National Institutes of Health (NIH) Monica M. Bertagnolli, MD, FACS, FASCO, to its Board of Directors. “Dr. Bertagnolli has built her incredible career around improving the lives of patients through a...

Jennifer A. Woyach, MD, Named The Ohio State’s Director of Hematology

The ASCO Post Staff  /  February 25, 2025

Jennifer A. Woyach, MD, a hematology cancer expert and researcher who has been with The Ohio State for more than 12 years, has been named Director of the Division of Hematology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research I...

Breast Cancer

Award Recipients Announced for the 2024 San Antonio Breast Cancer Symposium

The ASCO Post Staff  /  December 10, 2024

The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an SABCS cosponsor, will honor two researchers for their significant contributions to breast cancer research during the 2024 SABCS. 2024 AACR Distinguished Lectureship in Breast Cancer Research ...

Integrative Oncology

NCCN Joins International Cancer Organizations During Oncology Event in China

The ASCO Post Staff  /  December 10, 2024

The National Comprehensive Cancer Network (NCCN) took part in the 2024 International Congress of the Asian Oncology Society and the 2024 Chinese Congress on Holistic Integrative Oncology. This event highlighted international collaborations to improve cancer therapy and outcomes across China and Asia...

Skin Cancer

Roswell Park Announces Center’s First Physician-in-Chief

The ASCO Post Staff  /  December 10, 2024

Candace S. Johnson, PhD, President and Chief Executive Officer of Roswell Park Comprehensive Cancer Center, recently announced the appointment of Michael Wong, MD, PhD, FRPC, as the cancer center’s first Physician-in-Chief. Dr. Wong is a medical oncologist and skin cancer expert, who joined Roswel...

Advertisement

Advertisement




Advertisement